HRT Financial’s Filana Therapeutics FLNA Stock Holding History

HRT Financial’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-25,000	Closed	-$1.09M	–	3770
2021 Q4	$1.09M	Buy	25,000 +6,900	+38%	+$362K	0.01%	1033
2021 Q3	$1.12M	Buy	+18,100	New	+$1.51M	0.01%	1155

Other funds holding FLNA

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

HRT Financial's FLNA Position: Q1 2026 in Review

HRT Financial sold out of Filana Therapeutics (FLNA) in Q1 2026, closing a stake of 23,192 shares — an estimated $45K sold.

HRT Financial first reported a position in FLNA in Q2 2022 and held it in 5 quarters. The position peaked at $465K in Q1 2023. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

HRT Financial reported no remaining Filana Therapeutics position as of Q1 2026 after selling out during the quarter.
HRT Financial sold 23,192 Filana Therapeutics shares in Q1 2026, an estimated $45K.
HRT Financial first reported a position in Filana Therapeutics in Q2 2022 and held it in 5 quarters.
HRT Financial's Filana Therapeutics position peaked at $465K in Q1 2023.
101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.